ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)

Journal of the American College of Cardiology

Volumn 31, Issue 5, 1998, Pages 1175-1209

  Gregoratos, Gabriel ^a   Cheitlin, Melvin D ^a   Conill, Alicia ^a   Epstein, Andrew E ^a   Fellows, Christopher ^a   Ferguson, T Bruce ^a   Freedman, Roger A ^a   Hlatky, Mark A ^a   Naccarelli, Gerald V ^a   Saksena, Sanjeev ^a   Schlant, Robert C ^a   Silka, Michael J ^a   Ritchie, James L ^a   Gibbons, Raymond J ^a   Eagle, Kim A ^a   Gardner, Timothy J ^a   Lewis, Richard P ^a   O'Rourke, Robert A ^a   Ryan, Thomas J ^a   Garson Jr , Arthur ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ANTIARRHYTHMIC ACTIVITY; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CARDIOVERSION; CAROTID SINUS; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; HEART RIGHT VENTRICLE DYSPLASIA; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMPLANTATION; LONG QT SYNDROME; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; SINUS NODE DYSFUNCTION; SUDDEN DEATH; TACHYCARDIA;

EID: 0032053695     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00024-2     Document Type: Conference Paper

References (335)

1. 1. Iskos D, Lurie KG, Sakaguchi S, Benditt DG. Termination of implantable pacemaker therapy: experience in 5 patients. Ann Intern Med 1997;126:787-90.
2. 2. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996;28:1328-428.
3. 3. Zipes DP, DiMarco JP, Gillette PC, et al. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiological and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 1995;26:555-73.
4. 4. Epstein AE, Carlson MD, Fogoros RN, Higgins SL, Venditti FJ. Classification of death in antiarrhythmia trials. J Am Coll Cardiol 1996;27:433-42.
5. 5. Kim SG, Fogoros RN, Furman S, et al. Standardized reporting of ICD patient outcome: the report of a North American Society of Pacing and Electrophysiology Policy Conference, February 9-10, 1993. PACE Pacing Clin Electrophysiol 1993;16:1358-62.
6. 6. Hayes DL, Naccarelli GV, Furman S, Parsonnet V. Report of the NASPE policy conference on training requirements for permanent pacemaker selection, implantation, and follow-up. North American Society of Pacing and Electrophysiology. PACE Pacing Clin Electrophysiol 1994;17:6-12.
7. 7. Josephson ME, Maloney JD, Barold SS, et al. ACC Core Cardiology Training Symposium (COCATS): guidelines for training in adult cardiovascular medicine. June 27-28, 1994. Task Force 6: training in specialized electrophysiology, cardiac pacing and arrhythmia management. J Am Coll Cardiol 1995;25:23-6.
8. 8. Freidberg CK, Donoso E, Stein WG. Nonsurgical acquired heart block. Ann N Y Acad Sci 1964;111:835-47.
9. 9. Gadboys HL, Wisoff BG, Litwak RS. Surgical treatment of complete heart block: an analysis of 36 cases. JAMA 1964;189:97-102.
10. 10. Johansson BW. Complete heart block: a clinical, hemodynamic and pharmacological study in patients with and without an artificial pacemaker. Acta Med Scand 1966;180 Suppl 451:1-127.
11. 11. Hindman MC, Wagner GS, JaRo M, et al. The clinical significance of bundle branch block complicating acute myocardial infarction: indications for temporary and permanent pacemaker insertion. Circulation 1978;58: 689-99.
12. 12. Donmoyer TL, DeSanctis RW, Austen WG. Experience with implantable pacemakers using myocardial electrodes in the management of heart block. Ann Thorac Surg 1967;3:218-27.
13. 13. Edhag O, Swahn A. Prognosis of patients with complete heart block or arrhythmic syncope who were not treated with artificial pacemakers: a long-term follow-up study of 101 patients. Acta Med Scand 1976;200:457-63.
14. 14. Mymin D, Mathewson FA, Tate RB, Manfreda J. The natural history of primary first-degree atrioventricular heart block. N Engl J Med 1986;315: 1183-7.
15. 15. Barold SS. Indications for permanent cardiac pacing in first-degree AV block: class I, II, or III? PACE Pacing Clin Electrophysiol 1996;19:747-51.
16. 16. Kim YH, O'Nunain S, Trouton T, et al. Pseudopacemaker syndrome following inadvertent fast pathway ablation for atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol 1993;4:178-82.
17. 17. Brecker SJD, Xiao HB, Sparrow J, Gibson DG. Effects of dual chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 1992;340:1308-12.
18. 18. Dhingra RC, Denes P, Wu D, Chuquimia R, Rosen KM. The significance of second degree atrioventricular block and bundle branch block: observations regarding site and type of block. Circulation 1974;49:638-46.
19. 19. Strasberg B, Amat-Y-Leon F, Dhingra RC, et al. Natural history of chronic second-degree atrioventricular nodal block. Circulation 1981;63:1043-9.
20. 20. Donoso E, Adler LN, Friedberg CK. Unusual forms of second-degree atrioventricular block, including Mobitz type-II block, associated with the Morgagni-Adams-Stokes syndrome. Am Heart J 1964;67:150-7.
21. 21. Recommendations for pacemaker prescription for symptomatic bradycardia: report of a working party of the British Pacing and Electrophysiology Group. Br Heart J 1991;66:185-91.
22. 22. Connelly DT, Steinhaus DM. Mobitz type I atrioventricular block: an indication for permanent pacing? PACE Pacing Clin Electrophysiol 1996; 19:261-4.
23. 23. Shaw DB, Kekwick CA, Veale D, Gowers J, Whistance T. Survival in second degree atrioventricular block. Br Heart J 1985;53:587-93.
24. 24. Ranganathan N, Dhurandhar R, Phillips JH, Wigle ED. His Bundle electrogram in bundle-branch block. Circulation 1972;45:282-94.
25. 25. Ector H, Rolies L, De Geest H. Dynamic electrocardiography and ventricular pauses of 3 seconds and more: etiology and therapeutic implications. PACE Pacing Clin Electrophysiol 1983;6:548-51.
26. 26. Shaw DB, Holman RR, Gowers JI. Survival in sinoatrial disorder (sick-sinus syndrome). Br Med J 1980;280:139-41.
27. 27. Kay R, Estioko M, Wiener I. Primary sick sinus syndrome as an indication for chronic pacemaker therapy in young adults: incidence, clinical features, and long-term evaluation. Am Heart J 1982;103:338-42.
28. 28. Gallagher JJ, Svenson RH, Kasell JH, et al. Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med 1982;306:194-200.
29. 29. Langberg JJ, Chin MC, Rosenqvist M, et al. Catheter ablation of the atrioventricular junction with radiofrequency energy. Circulation 1989;80: 1527-35.
30. 30. Kastor JA. Atrioventricular block (first of two parts). N Engl J Med 1975;292:462-5.
31. 30a. Glikson M, Dearani JA, Hyberger LK, Schaff HV, Hammill SC, Hayes DL. Indications, effectiveness, and long-term dependency in permanent pacing after cardiac surgery. Am J Cardiol 1997;80:1309-13.
32. 31. Perloff JK, Stevenson WG, Roberts NK, Cabeen W, Weiss J. Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): a prospective study of 25 patients. Am J Cardiol 1984;54:1074-81.
33. 32. Hiromasa S, Ikeda T, Kubota K, et al. Myotonic dystrophy: ambulatory electrocardiogram, electrophysiologic study, and echocardiographic evaluation. Am Heart J 1987;113:1482-8.
34. 33. Stevenson WG, Perloff JK, Weiss JN, Anderson TL. Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvement. J Am Coll Cardiol 1990;15:292-9.
35. 34. James TN, Fisch C. Observations on the cardiovascular involvement in Friedreich's ataxia. Am Heart J 1963;66:164-75.
36. 35. Roberts NK, Perloff JK, Kark RAP. Cardiac conduction in the Kearns-Sayre syndrome (a neuromuscular disorder associated with progressive external ophthalmoplegia and pigmentary retinopathy): report of 2 cases and review of 17 published cases. Am J Cardiol 1979;44:1396-1400.
37. 36. Charles R, Holt S, Kay JM, Epstein EJ, Rees JR. Myocardial ultrastructure and the development of atrioventricular block in Kearns-Sayre syndrome. Circulation 1981;63:214-9.
38. 37. James TN. Observations on the cardiovascular involvement, including the conduction system, in progressive muscular dystrophy. Am Heart J 1962; 63:48-56.
39. 38. McAlister HF, Klementowicz PT, Andrews C, Fisher JD, Feld M, Furman S. Lyme carditis: an important cause of reversible heart block. Ann Intern Med 1989;110:339-45.
40. 39. Penton GB, Miller H, Levine SA. Some clinical features of complete heart block. Circulation 1956;13:801-24.
41. 40. Kulbertus H, Collignon P. Association of right bundle-branch block with left superior or inferior intraventricular block: its relation to complete heart block and Adams-Stokes syndrome. Br Heart J 1969;31:435-40.
42. 41. DePasquale NP, Bruno MS. Natural history of combined right bundle branch block and left anterior hemiblock (bilateral bundle branch block). Am J Med 1973;54:297-303.
43. 42. Dhingra RC, Denes P, Wu D, et al. Syncope in patients with chronic bifascicular block: significance, causative mechanisms, and clinical implications. Ann Intern Med 1974;81:302-6.
44. 43. Scheinman MM, Peters RW, Modin G, Brennan M, Mies C, O'Young J. Prognostic value of infranodal conduction time in patients with chronic bundle branch block. Circulation 1977;56:240-4.
45. 44. Denes P, Dhingra RC, Wu D, Wyndham CR, Amat-Y-Leon F, Rosen KM. Sudden death in patients with chronic bifascicular block. Arch Intern Med 1977;137:1005-10.
46. 45. McAnulty JH, Kauffman S, Murphy E, Kassebaum DG, Rahimtoola SH. Survival in patients with intraventricular conduction defects. Arch Intern Med 1978;138:30-5.
47. 46. Peters RW, Scheinman MM, Modin C, O'Young J, Somelofski CA, Mies C. Prophylactic permanent pacemakers for patients with chronic bundle branch block. Am J Med 1979;66:978-85.
48. 47. Fisch GR, Zipes DP, Fisch C. Bundle branch block and sudden death. Prog Cardiovasc Dis 1980;23:187-224.
49. 48. McAnulty JH, Rahimtoola SH, Murphy E, et al. Natural history of "high-risk" bundle-branch block: final report of a prospective study. N Engl J Med 1982;307:137-43.
50. 49. Scheinman MM, Peters RW, Suavé MJ, et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 1982;50:1316-22.
51. 50. Morady F, Higgins J, Peters RW, et al. Electrophysiologic testing in bundle branch block and unexplained syncope. Am J Cardiol 1984;54:587-91.
52. 51. Click RL, Gersh BJ, Sugrue DD, et al. Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block. Am J Cardiol 1987;59:817-23.
53. 52. Lie KL, Wellens HJJ, Schuilenburg RM. Bundle branch block and acute myocardial infarction. In: Wellens HJJ, Lie KI, Janse MD, editors. The Conduction System of the Heart: Structure, Function and Clinical Implications. Philadelphia (PA): Lea & Febiger, 1976:662-72.
54. 53. Ezri M, Lerman BB, Marchlinski FE, Buxton AE, Josephson ME. Electrophysiologic evaluation of syncope in patients with bifascicular block. Am Heart J 1983;106:693-7.
55. 54. Twidale N, Heddle WF, Ayres BF, Tonkin AM. Clinical implications of electrophysiology study findings in patients with chronic bifascicular block and syncope. Aust NZJ Med 1988;18:841-7.
56. 55. Englund A, Bergfeldt L, Rehnqvist N, Åström H, Rosenqvist M. Diagnostic value of programmed ventricular stimulation in patients with bifascicular block: a prospective study of patients with and without syncope. J Am Coll Cardiol 1995;26:1508-15.
57. 56. Probst P, Pachinger O, Akbar Murad A, Leisch F, Kaindl F. The HQ time in congestive cardiomyopathies. Am Heart J 1979;97:436-41.
58. 57. Dhingra RC, Wyndham C, Bauernfeind R, et al. Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block. Circulation 1979;60:1455-64.
59. 58. Cheng TO. Atrial pacing: its diagnostic and therapeutic applications. Prog Cardiovasc Dis 1971;14:230-47.
60. 59. Gupta PK, Lichstein E, Chadda KD. Intraventricular conduction time (H-V interval) during antegrade conduction in patients with heart block. Am J Cardiol 1973;32:27-31.
61. 60. Altschuler H, Fisher JD, Furman S. Significance of isolated H-V interval prolongation in symptomatic patients without documented heart block. Am Heart J 1979;97:19-26.
62. 61. Col JJ, Weinberg SL. The incidence and mortality of intraventricular conduction defects in acute myocardial infarction. Am J Cardiol 1972;29: 344-50.
63. 62. Ritter WS, Atkins JM, Blomqvist CG, Mullins CB. Permanent pacing in patients with transient trifascicular block during acute myocardial infarction. Am J Cardiol 1976;38:205-8.
64. 63. Ginks WR, Sutton R, Oh W, Leatham A. Long-term prognosis after acute anterior infarction with atrioventricular block. Br Heart J 1977;39:186-9.
65. 64. Domenighetti G, Perret C. Intraventricular conduction disturbances in acute myocardial infarction: short- and long-term prognosis. Eur J Cardiol 1980;11:51-9.
66. 65. Lamas GA, Muller JE, Turi ZG, et al. A simplified method to predict occurrence of complete heart block during acute myocardial infarction. Am J Cardiol 1986;57:1213-9.
67. 66. Juma Z, Castellanos A, Myerburg RJ. Prognostic significance of the electrocardiogram in patients with coronary heart disease. In: Wellens HJJ, Kulbertus HE, editors. What's New in Electrocardiography. The Hague: Martinus Nijhoff Publishers, 1981:5-22.
68. 67. Clemmensen P, Bates ER, Califf RM, et al. Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy. Am J Cardiol 1991;67:225-30.
69. 68. Goldberg RJ, Zevallos JC, Yarzebski J, et al. Prognosis of acute myocardial infarction complicated by complete heart block (the Worcester Heart Attack Study). Am J Cardiol 1992;69:1135-41.
70. 69. Behar S, Zissman E, Zion M, et al. Prognostic significance of second-degree atrioventricular block in inferior wall acute myocardial infarction. Am J Cardiol 1993;72:831-4.
71. 70. Berger PB, Ruocco NA, Ryan TJ, et al. Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II. J Am Coll Cardiol 1992;20: 533-40.
72. 71. Nicod P, Gilpin E, Dittrich H, Polikar R, Henning H, Ross J Jr. Long-term outcome in patients with inferior myocardial infarction and complete atrioventricular block. J Am Coll Cardiol 1988;12:589-94.
73. 72. Dubois C, Piérard LA, Smeets JP, Carlier J, Kulbertus HE. Long-term prognostic significance of atrioventricular block in inferior acute myocardial infarction. Eur Heart J 1989;10:816-20.
74. 73. Kusumoto FM, Goldschlager N. Cardiac pacing. N Engl J Med 1996;334: 89-97.
75. 74. Linde-Edelstam C, Nordlander R, Pehrsson SK, Ryden L. A double-blind study of submaximal exercise tolerance and variation in paced rate in atrial synchronous compared to activity sensor modulated ventricular pacing. PACE Pacing Clin Electrophysiol 1992;15:905-15.
76. 75. Gammage M, Schofield S, Rankin I, Bennett M, Coles P, Pentecost B. Benefit of single setting rate responsive ventricular pacing compared with fixed rate demand pacing in elderly patients. PACE Pacing Clin Electrophysiol 1991;14:174-80.
77. 76. Meytes I, Kaplinsky E, Yahini JH, Hanne-Paparo N, Neufeld HN. Wenckebach A-V block: a frequent feature following heavy physical training. Am Heart J 1975;90:426-30.
78. 77. Talan DA, Bauernfeind RA, Ashley WW, Kanakis CJ, Rosen KM. Twenty-four hour continuous ECG recordings in long-distance runners. Chest 1982;82:19-24.
79. 78. Dreifus LS, Michelson EL, Kaplinsky E. Bradyarrhythmias: clinical significance and management. J Am Coll Cardiol 1983;1:327-38.
80. 79. Rasmussen K. Chronic sinus node disease: natural course and indications for pacing. Eur Heart J 1981;2:455-9.
81. 80. Rubenstein JJ, Schulman CL, Yurchak PM, DeSanctis RW. Clinical spectrum of the sick sinus syndrome. Circulation 1972;46:5-13.
82. 81. Rosenqvist M, Brandt J, Schuller H. Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988;116:16-22.
83. 82. Santini M, Alexidou G, Ansalone G, Cacciatore G, Cini R, Turitto G. Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing. Am J Cardiol 1990;65:729-35.
84. 83. Connolly SJ, Kerr C, Gent M, Yusuf S. Dual-chamber versus ventricular pacing: critical appraisal of current data. Circulation 1996;94:578-83.
85. 84. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PE. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994;344:1523-8.
86. 84a.Anderson HR, Nielsen JC, Thomsen PEB, et al. Long-term follow up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210-6.
87. 85. Spurrell RA, Nathan AW, Camm AJ. Clinical experience with implantable scanning tachycardia reversion pacemakers. PACE Pacing Clin Electrophysiol 1984;7:1296-1300.
88. 86. Peters RW, Scheinman MM, Morady F, Jacobson L. Long-term management of recurrent paroxysmal tachycardia by cardiac burst pacing. PACE Pacing Clin Electrophysiol 1985;8:35-44.
89. 87. Fisher JD, Johnston DR, Furman S, Mercando AD, Kim SG. Long-term efficacy of antitachycardia pacing for supraventricular and ventricular tachycardias. Am J Cardiol 1987;60:1311-6.
90. 88. Den Dulk K, Bertholet M, Brugada P, et al. Clinical experience with implantable devices for control of tachyarrhythmias. PACE Pacing Clin Electrophysiol 1984;7:548-56.
91. 89. Herre JM, Griffin JC, Nielsen AP, et al. Permanent triggered antitachycardia pacemakers in the management of recurrent sustained ventricular tachycardia. J Am Coll Cardiol 1985;6:206-14.
92. 90. Saksena S, Pantopoulos D, Parsonnet V, Rothbart ST, Hussain SM, Gielchinsky I. Usefulness of an implantable antitachycardia pacemaker system for supraventricular or ventricular tachycardia. Am J Cardiol 1986;58:70-4.
93. 91. Barold SS, Wyndham CR, Kappenberger LL, Abinader EG, Griffin JC, Falkoff MD. Implanted atrial pacemakers for paroxysmal atrial flutter: long-term efficacy. Ann Intern Med 1987;107:144-9.
94. 92. Attuel P, Pellerin D, Mugica J, Coumel P. DDD pacing: an effective treatment modality for recurrent atrial arrhythmias. PACE Pacing Clin Electrophysiol 1988;11:1647-54.
95. 93. Saksena S, Prakash A, Hill M, et al. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 1996;28:687-94.
96. 94. Daubert C, Mabo P, Berder V. Arrhythmia prevention by permanent atrial resynchronization in advanced intratrial block. Eur Heart J 1990;11:237-42.
97. 95. Ward DE, Camm AJ, Spurrell RA. The response of regular re-entrant supraventricular tachycardia to right heart stimulation. PACE Pacing Clin Electrophysiol 1979;2:586-95.
98. 96. Naccarelli GV, Zipes DP, Rahilly GT, Heger JJ, Prystowsky EN. Influence of tachycardia cycle length and antiarrhythmic drugs on pacing termination and acceleration of ventricular tachycardia. Am Heart J 1983;105:1-5.
99. 97. Eldar M, Griffin JC, Abbott JA, et al. Permanent cardiac pacing in patients with the long QT syndrome. J Am Coll Cardiol 1987;10:600-7.
100. 98. Eldar M, Griffin JC, Van Hare GF, et al. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. J Am Coll Cardiol 1992;20:830-7.
101. 99. Moss AJ, Robinson J. Clinical features of the idiopathic long QT syndrome. Circulation 1992;85(suppl I):I-140-4.
102. 100. Naccarelli GV, Dougherty AH, Jalal S, Shih HT, Wolbrette D. Paroxysmal supraventricular tachycardia: comparative role of therapeutic methods - drugs, devices and ablation. In: Saksena S, Luderitz B, editors. Interventional Electrophysiology: A Textbook. Armonk (NY): Futura Publishing Co, Inc, 1996:381-90.
103. 101. Fisher JD, Teichman SL, Ferrick A, Kim SG, Waspe LE, Martinez MR. Antiarrhythmic effects of VVI pacing at physiologic rates: a crossover controlled evaluation. PACE Pacing Clin Electrophysiol 1987;10:822-30.
104. 102. Lau CP, Cornu E, Camm AJ. Fatal and nonfatal cardiac arrest in patients with an implanted antitachycardia device for the treatment of supraventricular tachycardia. Am J Cardiol 1988;61:919-21.
105. 103. Mehta D, Saksena S, Krol RB, Makhija V. Comparison of clinical benefits and outcome in patients with programmable and nonprogrammable implantable cardioverter defibrillators. PACE Pacing Clin Electrophysiol 1992;15:1279-90.
106. 104. Saksena S, Poczobutt-Johanos M, Castle LW, et al. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group. J Am Coll Cardiol 1992;19:490-9.
107. 105. Bardy GH, Troutman C, Poole JE, et al. Clinical experience with a tiered-therapy, multiprogrammable antiarrhythmia device. Circulation 1992;85:1689-98.
108. 106. Sra JS, Jazayeri MR, Avitall B, et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993;328:1085-90.
109. 107. Sugrue DD, Gersh BJ, Holmes DR, Wood DL, Osborn MJ, Hammill SC. Symptomatic 'isolated' carotid sinus hypersensitivity: natural history and results of treatment with anticholinergic drugs or pacemaker. J Am Coll Cardiol 1986;7:158-62.
110. 108. Peretz DI, Gerein AN, Miyagishima RT. Permanent demand pacing for hypersensitive carotid sinus syndrome. Can Med Assoc J 1973;108:1131-4.
111. 109. Brignole M, Menozzi C, Gianfranchi L, Oddone D, Lolli G, Bertulla A. Neurally mediated syncope detected by carotid sinus massage and head-up tilt test in sick sinus syndrome. Am J Cardiol 1991;68:1032-6.
112. 110. Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol 1996;28:263-75.
113. 111. Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P. Proposed classification for tilt-induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1992;2:180-3.
114. 112. Kenny RA, Ingram A, Bayliss J, Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet 1986;1:1352-5.
115. 113. Fitzpatrick A, Sutton R. Tilting towards a diagnosis in recurrent unexplained syncope. Lancet 1989;1:658-60.
116. 114. Petersen ME, Chamberlain-Webber R, Fitzpatrick AP, Ingram A, Williams T, Sutton R. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994;71:274-81.
117. 115. Connolly SJ, Sheldon RS, Gent M, Roberts RS, VPS Investigators. A randomized trial of cardiac pacing for recurrent fainting: the Vasovagal Pacemaker Study (VPS). Presented at the North American Society of Pacing and Electrophysiology 18th Annual Scientific Session; May 1997; New Orleans, La.
118. 116. Grubb BP, Gerard G, Roush K, et al. Differentiation of convulsive syncope and epilepsy with head up tilt testing. Ann Intern Med 1991;115:871-6.
119. 117. Fisher JD. Role of electrophysiologic testing in the diagnosis and treatment of patients with known and suspected bradycardias and tachycardias. Prog Cardiovasc Dis 1981;24:25-90.
120. 118. Reiffel JA, Kuehnert MJ. Electrophysiological testing of sinus node function: diagnostic and prognostic application - including updated information from sinus node electrograms. PACE Pacing Clin Electrophysiol 1994;17: 349-65.
121. 119. Mackintosh AF. Sinuatrial disease in young people. Br Heart J 1981;45: 62-6.
122. 120. Garson A Jr, Bink-Boelkens M, Hesslein PS, et al. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol 1985;6:871-8.
123. 121. Gelatt M, Hamilton RM, McCrindle BW, et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol 1997;29:194-201.
124. 122. Silka MJ, Manwill JR, Kron J, McAnulty JH. Bradycardia-mediated tachyarrhythmias in congenital heart disease and responses to chronic pacing at physiologic rates. Am J Cardiol 1990;65:488-93.
125. 123. Gillette PC, Zeigler VL, Case CL, Harold M, Buckles DS. Atrial antitachycardia pacing in children and young adults. Am Heart J 1991;122:844-9.
126. 124. Rhodes LA, Walsh EP, Gamble WJ, Triedman JK, Saul JP. Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease. PACE Pacing Clin Electrophysiol 1995;18:1005-16.
127. 125. Kugler JD, Danford DA. Pacemakers in children: an update. Am Heart J 1989;117:665-79.
128. 126. Sholler GF, Walsh EP. Congenital complete heart block in patients without anatomic cardiac defects. Am Heart J 1989;118:1193-8.
129. 127. Michaelsson M, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life: a prospective study. Circulation 1995; 92:442-9.
130. 128. Dewey RC, Capeless MA, Levy AM. Use of ambulatory electrocardiographic monitoring to identify high-risk patients with congenital complete heart block. N Engl J Med 1987;316:835-9.
131. 129. Pinsky WW, Gillette PC, Garson A Jr, McNamara DG. Diagnosis, management, and long-term results of patients with congenital complete atrioventricular block. Pediatrics 1982;69:728-33.
132. 130. Michaelsson M, Engle MA. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin 1972;4:85-101.
133. 131. Moss AJ, Liu JE, Gottlieb S, Locati EH, Schwartz PJ, Robinson JL. Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome. Circulation 1991;84:1524-9.
134. 132. Viskin S, Alla SR, Barren HV, et al. Mode of onset of torsade de pointes in congenital long QT syndrome. J Am Coll Cardiol 1996;28:1262-8.
135. 133. Trippel DL, Parsons MK, Gillette PC. Infants with long-QT syndrome and 2:1 atrioventricular block. Am Heart J 1995;130:1130-4.
136. 134. Solti F, Szatmary L, Vecsey T, Renyi-Vamos FJ, Bodor E. Congenital complete heart block associated with QT prolongation. Eur Heart J 1992;13:1080-3.
137. 135. Lillehei CW, Sellers RD, Bonnanbeau RC, Eliot RS. Chronic postsurgical complete heart block with particular reference to prognosis, management, and a new P-wave pacemaker. J Thorac Cardiovasc Surg 1963;46:436-56.
138. 136. Kertesz N, McQuinn T, Collins E, Friedman R. Surgical atrioventricular block in 888 congenital heart operations: new implications for early implantation of a permanent pacemaker [abstract]. PACE Pacing Clin Electrophysiol 1996;19:613.
139. 137. Krongrad E. Prognosis for patients with congenital heart disease and post-operative intraventricular conduction defects. Circulation 1978;57: 867-70.
140. 138. Silka MJ, Rice MJ. Paradoxic embolism due to altered hemodynamic sequencing following transvenous pacing. PACE Pacing Clin Electrophysiol 1991;14:499-503.
141. 139. Lau YR, Gillette PC, Buckles DS, Zeigler VL. Actuarial survival of transvenous pacing leads in a pediatric population. PACE Pacing Clin Electrophysiol 1993;16:1363-7.
142. 140. Greenspan AM, Kay HR, Berger BC, Greenberg RM, Greenspon AJ, Gaughan MJ. Incidence of unwarranted implantation of permanent cardiac pacemakers in a large medical population. N Engl J Med 1988;318:158-63.
143. 141. McDonald K, McWilliams E, O'Keeffe B, Maurer B. Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy. Eur Heart J 1988;9:893-8.
144. 142. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994;90:2731-42.
145. 143. Fananapazir L, Cannon RO, Tripodi D, Panza JA. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation 1992;85:2149-61.
146. 144. Prinzen FW, Cheriex EC, Delhaas T, et al. Asymmetric thickness of the left ventricular wall resulting from asynchronous electric activation: a study in dogs with ventricular pacing and in patients with left bundle branch block. Am Heart J 1995;130:1045-53.
147. 145. Nishimura RA, Hayes DL, Ilstrup DM, Holmes DR, Tajik AJ. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy: acute Doppler echocardiographic and catheterization hemodynamic study. J Am Coll Cardiol 1996;27:421-30.
148. 146. Nishimura RA, Symanski JD, Hurrell DG, Trusty JM, Hayes DL, Tajik AJ. Dual-chamber pacing for cardiomyopathies: a 1996 clinical perspective. Mayo Clin Proc 1996;71:1077-87.
149. 147. Jeanrenaud X, Schlapper J, Fromer M, Aebischer N, Kappenberger L. Dual chamber pacing in hypertrophic obstructive cardiomyopathy: beneficial effect of atrioventricular junction ablation of optimal left ventricular capture and filling. PACE Pacing Clin Electrophysiol 1997;20:293-300.
150. 148. Spirito P, McKenna WJ, Schultheiss HP. DDD pacing in obstructive HCM. Circulation 1995;92:1670-3.
151. 149. Slade AK, Sadoul N, Shapiro L, et al. DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience. Heart 1996;75:44-9.
152. 150. Betocchi S, Losi MA, Piscione F, et al. Effects of dual-chamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and on diastolic function. Am J Cardiol 1996;77:498-502.
153. 151. Cannon RO, Tripodi D, Dilsizian V, Panza JA, Fananapazir L. Results of permanent dual chamber pacing in symptomatic nonobstructive hypertrophic cardiomyopathy. Am J Cardiol 1994;73:571-6.
154. 152. Kappenberger L, Linde C, Daubert C, et al. Pacing in hypertrophic obstructive cardiomyopathy (PIC): a randomized crossover study. Eur Heart J 1997;18:1249-56.
155. 153. Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992;339:1318-23.
156. 154. Nishimura RA, Trusty JM, Hayes DL, et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 1997;29:435-41.
157. 155. Rishi F, Hulse JE, Auld DO, et al. Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1997;29:734-40.
158. 156. Nishimura RA, Hayes DL, Holmes DR, Tajik AJ. Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study. J Am Coll Cardiol 1995;25:281-8.
159. 157. Hochleitner M, Hortnagl H, Fridrich L, Gschnitzer F. Long-term efficacy of physiologic dual-chamber pacing in the treatment of end-stage idiopathic dilated cardiomyopathy. Am J Cardiol 1992;70:1320-5.
160. 158. Auricchio A, Sommariva L, Salo RW, Scafuri A, Chiariello L. Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease by dual chamber pacing with shortened AV delay. PACE Pacing Clin Electrophysiol 1993;16:2034-43.
161. 159. Linde C, Gadler F, Edner M, Nordlander R, Rosenqvist M, Ryden L. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol 1995;75:919-23.
162. 160. Gold MR, Feliciano Z, Gottlieb SS, Fisher ML. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. J Am Coll Cardiol 1995;26:967-73.
163. 161. Innes D, Leitch JW, Fletcher PJ. VDD pacing at short atrioventricular intervals does not improve cardiac output in patients with dilated heart failure. PACE Pacing Clin Electrophysiol 1994;17:959-65.
164. 162. Giudici MC, Thornburg GA, Buck DL, et al. Comparision of right ventricular outflow tract and apical lead permanent pacing on cardiac output. Am J Cardiol 1997;79:209-12.
165. 163. Saxon LA, Cahalan MK, Merrick SH, et al. Effects of multi-site ventricular pacing in dilated cardiomyopathy [abstract]. PACE Pacing Clin Electrophysiol 1996;19:641.
166. 164. Cazaeu S, Ritter P, Lazarus A, Gras D, Mujica J. Multisite pacing for congestive heart failure [abstract]. PACE Pacing Clin Electrophysiol 1996; 19:568.
167. 165. DiBiase A, Tse TM, Schnittger I, Wexler L, Stinson EB, Valantine HA. Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol 1991;67:1385-9.
168. 166. Heinz G, Hirschl M, Buxbaum P, Laufer G, Gasic S, Laczkovics A. Sinus node dysfunction after orthotopic cardiac transplantation: postoperative incidence and long-term implications. PACE Pacing Clin Electrophysiol 1992;15:731-7.
169. 167. Scott CD, Dark JH, McComb JM. Sinus node function after cardiac transplantation. J Am Coll Cardiol 1994;24:1334-41.
170. 168. Scott CD, Omar I, McComb JM, Dark JH, Bexton RS. Long-term pacing in heart transplant recipients is usually unnecessary. PACE Pacing Clin Electrophysiol 1991;14:1792-6.
171. 169. Montero JA, Anguita M, Concha M, et al. Pacing requirements after orthotopic heart transplantation: incidence and related factors. J Heart Lung Transplant 1992;11:799-802.
172. 170. Payne ME, Murray KD, Watson KM, et al. Permanent pacing in heart transplant recipients: underlying causes and long-term results. J Heart Lung Transplant 1991;10:738-42.
173. 171. Grinstead WC, Smart FW, Pratt CM, et al. Sudden death caused by bradycardia and asystole in a heart transplant patient with coronary arteriopathy. J Heart Lung Transplant 1991;10:931-6.
174. 172. Bertolet BD, Eagle DA, Conti JB, Mills RM Jr, Belardinelli L. Bradycardia after heart transplantation: reversal with theophylline. J Am Coll Cardiol 1996;28:396-9.
175. 173. Bernstein AD, Camm AJ, Fletcher RD, et al. The NASPE/BPEG generic pacemaker code for antibradyarrhythmia and adaptive-rate pacing and antitachyarrhythmia devices. PACE Pacing Clin Electrophysiol 1987;10: 794-9.
176. 174. Toivonen L, Lommi J. Dependence of atrial sensing function on posture in a single-lead atrial triggered ventricular (VDD) pacemaker. PACE Pacing Clin Electrophysiol 1996;19:309-13.
177. 175. Mond H, Stokes K, Helland J, et al. The porous titanium steroid eluting electrode: a double blind study assessing the stimulation threshold effects of steroid. PACE Pacing Clin Electrophysiol 1988;11:214-9.
178. 176. Crossley GH, Reynolds D, Kay GN, et al. Treatment of patients with prior exit block using a novel steroid-eluting active fixation lead. Model 4068 Investigators. PACE Pacing Clin Electrophysiol 1994;17:2042-6.
179. 177. Karpawich PP, Hakimi M, Arciniegas E, Cavitt DL. Improved chronic epicardial pacing in children: steroid contribution to porous platinized electrodes. PACE Pacing Clin Electrophysiol 1992;15:1151-7.
180. 178. Mond HG, Helland JR. Engineering and clinical aspects of pacing leads. In: Ellenbogen KA, Kay GN, Wilkoff BL, editors. Clinical Cardiac Pacing. Philadelphia (PA): WB Saunders, 1995:69-90.
181. 179. Ovsyshcher IE. Matching optimal pacemaker to patient: do we need a large scale clinical trial of pacemaker mode selection? PACE Pacing Clin Electrophysiol 1995;18:1845-52.
182. 180. Linde C. How to evaluate quality-of-life in pacemaker patients: problems and pitfalls. PACE Pacing Clin Electrophysiol 1996;19:391-7.
183. 181. Van Hemel NM. Pacemakers and quality of life. Eur J Cardiac Pacing Electrophysiol 1993;1:27-28.
184. 182. Adornato E, Bacca F, Polimeni RM. Ventricular single-chamber RR pacing in comparision to dual-chamber RR pacing: preliminary results of an Italian multicenter trial [abstract]. PACE Pacing Clin Electrophysiol 1993; 16:1147.
185. 183. Barrington WW, Windle JR, Easley AA, Rundlett R, Eisenger G. Clinical comparison of acute single to dual chamber pacing in chronotropically incompetent patients with left ventricular dysfunction. PACE Pacing Clin Electrophysiol 1995;18:433-40.
186. 184. Brandt J, Schuller H. Pacing for sinus node disease: a therapeutic rationale. Clin Cardiol 1994;17:495-8.
187. 185. Lamas GA, Estes NM, Schneller S, Flaker GC. Does dual chamber or atrial pacing prevent atrial fibrillation? The need for a randomized controlled trial. PACE Pacing Clin Electrophysiol 1992;15:1109-13.
188. 186. Rosenqvist M, Obel IW. Atrial pacing and the risk for AV block: is there a time for change in attitude? PACE Pacing Clin Electrophysiol 1989;12: 97-101.
189. 187. Brandt J, Anderson H, Fahraeus T, Schuller H. Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode. J Am Coll Cardiol 1992;20:633-9.
190. 188. Katritsis D, Camm AJ. AAI pacing mode: when is it indicated and how should it be achieved? Clin Cardiol 1993;16:339-43.
191. 189. Sutton R, Kenny RA. The natural history of sick sinus syndrome. PACE Pacing Clin Electrophysiol 1986;9:1110-4.
192. 190. Haywood GA, Ward J, Ward DE, Camm AJ. Atrioventricular Wenckebach point and progression to atrioventricular block in sinoatrial disease. PACE Pacing Clin Electrophysiol 1990;13:2054-8.
193. 191. Mabo P, Pouillot C, Kermarrec A, Lelong B, Lebreton H, Daubert C. Lack of physiological adaptation of the atrioventricular interval to heart rate in patients chronically paced in the AAIR mode. PACE Pacing Clin Electrophysiol 1991;14:2133-42.
194. 192. Alpert MA, Curtis JJ, Sanfelippo JF, et al. Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure. J Am Coll Cardiol 1986;7:925-32.
195. 193. Bernstein AD, Parsonnet V. Survey of cardiac pacing and defibrillation in the United States in 1993. Am J Cardiol 1996;78:187-96.
196. 194. Channon KM, Hargreaves MR, Cripps TR, Gardner M, Ormerod OJ. DDD vs. VVI pacing in patients aged over 75 years with complete heart block: a double-blind crossover comparison. QJM 1994;87:245-51.
197. 195. Lamas GA, Pashos CL, Normand SL, McNeil B. Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. Circulation 1995;91:1063-9.
198. 196. Crossley GH, Gayle DD, Simmons TW, Haisty WK, Bailey JR, Davis-O'Brien K. Reprogramming pacemakers enhances longevity and is cost-effective. Circulation 1996;94 Suppl II:II-245-7.
199. 197. McGregor M. The reuse of cardiac pacemakers. Can J Cardiol 1992;8:697-701.
200. 198. Bernstein AD, Irwin ME, Parsonnet V, et al. Report of the NASPE Policy Conference on antibradycardia pacemaker follow-up: effectiveness, needs, and resources. PACE Pacing Clin Electrophysiol 1994;17:1714-29.
201. 199. Levine PA, Belott PH, Bilitch M, et al. Recommendations of the NASPE policy conference on pacemaker programmability and follow-up programs. PACE Pacing Clin Electrophysiol 1983;6:1222-3.
202. 200. Levine PA. Proceedings of the policy conference of the North American Society of Pacing and Electrophysiology on programmability and pacemaker follow-up programs. Clin Prog Pacing Electrophysiol 1984;2:145-91.
203. 201. Medicare Coverage Issues Manual. US Dept of Health and Human Services, Health Care Financing Administration. HCFA-Pub. 6 Thur Rev. 42. 1990.
204. 202. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-4.
205. 203. Lehmann MH, Steinman RT, Schuger CD, Jackson K. The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction. Am J Cardiol 1988;62:803-5.
206. 204. Saksena S, Breithardt G, Dorian P, Greene HL, Madan N, Block M. Nonpharmacological therapy for malignant ventricular arrhythmias: implantable defibrillator trials. Prog Cardiovasc Dis 1996;38:429-44.
207. 205. Tchou PJ, Kadri N, Anderson J, Caceres JA, Jazayeri M, Akhtar M. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Intern Med 1988;109:529-34.
208. 206. Fogoros RN, Fiedler SB, Elson JJ. The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias. Ann Intern Med 1987;107:635-41.
209. 207. Winkle RA, Mead RH, Ruder MA, et al. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989; 13:1353-61.
210. 208. Fogoros RN, Elson JJ, Bonnet CA, Fiedler SB, Burkholder JA. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol 1990;16:381-6.
211. 209. Newman D, Sauve MJ, Herre J, et al. Survival after implantation of the cardioverter defibrillator. Am J Cardiol 1992;69:899-903.
212. 210. Powell AC, Fuchs T, Finkelstein DM, et al. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation 1993;88:1083-92.
213. 211. Crandall BG, Morris CD, Cutler JE, et al. Implantable cardioverter-defibrillator therapy in survivors of out-of-hospital sudden cardiac death without inducible arrhythmias. J Am Coll Cardiol 1993;21:1186-92.
214. 212. Mehta D, Saksena S, Krol RB, et al. Device use patterns and clinical outcome of implantable cardioverter defibrillator patients with moderate and severe impairment of left ventricular function. PACE Pacing Clin Electrophysiol 1993;16:179-85.
215. 213. Nisam S, Kaye SA, Mower MM, Hull M. AICD automatic cardioverter defibrillator clinical update: 14 years experience in over 34,000 patients. PACE Pacing Clin Electrophysiol 1995;18:142-7.
216. 214. Porterfield JG, Porterfield LM, Smith BA, Bray L. Experience with three different third-generation cardioverter-defibrillators in patients with coronary artery disease or cardiomyopathy. Am J Cardiol 1993;72:301-4.
217. 215. Axtell K, Tchou P, Akhtar M. Survival in patients with depressed left ventricular function treated by implantable cardioverter defibrillator. PACE Pacing Clin Electrophysiol 1991;14:291-6.
218. 216. Saksena S, for the PCD Investigators. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. J Am Coll Cardiol 1994;23:1521-30.
219. 217. Zipes DP, Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator: a comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation 1995;92:59-65.
220. 218. Bardy GH, Yee R, Jung W. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. J Am Coll Cardiol 1996;28:400-10.
221. 219. Wever EF, Hauer RN, Schrijvers G, et al. Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors: a randomized study. Circulation 1996;93:489-96.
222. 220. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with prior myocardial infarction, low ejection fraction and asymptomatic non-sustained ventricular tachycardia. N Engl J Med 1996;335:1933-40.
223. 221. The AVID investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
224. 222. Saksena S, Krol RB, Kaushik RR. Innovations in pulse generators and lead systems: balancing complexity with clinical benefit and long-term results. Am Heart J 1994;127:1010-21.
225. 223. Timmis GC. The development of implantable cardioversion defibrillation systems: the clinical chronicle of defibrillation leads. Am Heart J 1994;127: 1003-9.
226. 224. Jung W, Manz M, Luderitz B. New technology for implantable cardioverter-debrillators: capacitors, lead systems, shock waveforms. In: Saksena S, Luderitz B, editors. Interventional Electrophysiology. 2nd ed. Armonk (NY): Futura Publishing Co; 1996:257-81.
227. 225. Grimm W, Flores BF, Marchlinski FE. Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator. Am J Cardiol 1993;71:1415-8.
228. 226. Song SL. Performance of implantable cardiac rhythm management devices. PACE Pacing Clin Electrophysiol 1994;17:692-708.
229. 227. Hook BG, Marchlinski FE. Value of ventricular electrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy. J Am Coll Cardiol 1991;17:985-90.
230. 228. Leitch JW, Gillis AM, Wyse DG, et al. Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy. J Am Coll Cardiol 1991;18:145-51.
231. 229. Luderitz B, Jung W, Deister A, Manz M. Quality of life in multiprogrammable ICD recipients. In: Saksena S, Luderitz B, editors. Interventional Electrophysiology. 2nd ed. Armonk (NY): Futura Publishing Co, 1996:305-13.
232. 230. Flowers NC, Abildskov JA, Armstrong WF, et al. ACC policy statement: recommended guidelines for training in adult clinical cardiac electrophysiology. Electrophysiology/Electrocardiography Subcommittee, American College of Cardiology. J Am Coll Cardiol 1991;18:637-40.
233. 231. Mirowski M, Reid PR, Winkle RA, et al. Mortality in patients with implanted automatic defibrillators. Ann Intern Med 1983;98:585-8.
234. 232. Saksena S, Camm AJ. Implantable defibrillators for prevention of sudden death: technology at a medical and economic crossroad. Circulation 1992;85:2316-21.
235. 233. Mehta D, Saksena S, Krol RB. Survival of implantable cardioverter-defibrillator recipients: role of left ventricular function and its relationship to device use. Am Heart J 1992;124:1608-14.
236. 234. Kim SG, Fisher JD, Choue CW, et al. Influence of left ventricular function on outcome of patients treated with implantable defibrillators. Circulation 1992;85:1304-10.
237. 235. Bocker D, Block M, Isbruch F, et al. Do patients with an implantable defibrillator live longer? J Am Coll Cardiol 1993;21:1638-44.
238. 236. Bocker D, Block M, Isbruch F, et al. Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest. Br Heart J 1995;73:158-63.
239. 237. Kim SG. Implantable defibrillator therapy: does it really prolong life? How can we prove it? Am J Cardiol 1993;71:1213-8.
240. 238. Borggrefe M, Chen X, Martinez-Rubio A, et al. The role of implantable cardioverter defibrillators in dilated cardiomyopathy. Am Heart J 1994;127: 1145-50.
241. 239. Silka MJ, Kron J, Dunnigan A, Dick M II. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society. Circulation 1993;87:800-7.
242. 240. Mason JW. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. N Engl J Med 1993;329:452-8.
243. 241. Teo KK, Yusuf S, Furburg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 1993;270:1589-95.
244. 242. Mitchell LB, Duff HJ, Gillis AM, Ramadan D, Wyse DG. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy for ventricular tachycardia: long-term follow-up of the Calgary trial. Prog Cardiovasc Dis 1996;38:377-84.
245. 243. Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (the CASCADE study). Am J Cardiol 1991;67:578-84.
246. 244. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.
247. 245. A randomized trial of propranolol in patients with acute myocardial infarction, I: mortality results. JAMA 1982;247:1707-14.
248. 246. Munsif AN, Saksena S. Efficacy of nadolol alone or in combination with a type IA antiarrhythmic drug in sustained ventricular tachycardia: a prospective study. PACE Pacing Clin Electrophysiol 1989;12:1816-26.
249. 247. Steinbeck G, Andresen D, Bach P, et al. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med 1992;327:987-92.
250. 248. Ceremuzynski L, Kleczar E, Krzeminska-Pakula M, et al. Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol 1992;20:1056-62.
251. 249. Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol 1990;16:1711-8.
252. 250. Julian DG, Camm AJ, Frangin G, et al. Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997;349:667-74.
253. 251. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997;349:675-82.
254. 252. Olson PJ, Woelfel A, Simpson RJ, Foster JR. Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation. Am J Cardiol 1993;71: 823-6.
255. 253. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995;333:77-82.
256. 254. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo di Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994;20:489-90.
257. 255. Ferguson TB Jr. The future of arrhythmia surgery. J Cardiovasc Electrophysiol 1994;5:621-34.
258. 256. Saksena S, Gielchinsky I, Tullo NG. Argon laser ablation of malignant ventricular tachycardia associated with coronary artery disease. Am J Cardiol 1989;64:1298-1304.
259. 257. Svenson RH, Littmann L, Gallagher JJ, et al. Termination of ventricular tachycardia with epicardial laser photocoagulation: a clinical comparison with patients undergoing successful endocardial photocoagulation alone. J Am Coll Cardiol 1990;15:163-70.
260. 258. Borggrefe M, Podczeck A, Ostermeyer J, Breithardt G, The Surgical Ablation Registry. Long-term results of electrophysiologically guided antitachycardia surgery in ventricular tachyarrhythmias: a collaborative report on 665 patients. In: Breithardt G, Borggrefe M, Zipes DP, editors. Nonpharmacological Therapy of Tachyarrhythmias. Mount Kisco (NY): Futura Publishing Inc, 1987:109-32.
261. 259. Stevenson WG, Khan H, Sager P, et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993;88:1647-70.
262. 260. Morady F, Harvey M, Kalbfleisch SJ, el-Atassi R, Calkins H, Langberg JJ. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation 1993;87:363-72.
263. 261. Gonska BD, Cao K, Schaumann A, Dorszewski A, von zur Muhlen F, Kreuzer H. Catheter ablation of ventricular tachycardia in 136 patients with coronary artery disease: results and long-term follow-up. J Am Coll Cardiol 1994;24:1506-14.
264. 262. Hindricks G. The Multicentre European Radiofrequency Survey (MERFS): complications of radiofrequency catheter ablation of arrhythmias. The Multicentre European Radiofrequency Survey (MERFS) investigators of the Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 1993;14:1644-53.
265. 263. Klein LS, Shih HT, Hackett FK, Zipes DP, Miles WM. Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation 1992;85:1666-74.
266. 264. Blanck Z, Dhala A, Deshpande S, Sra J, Jazayeri M, Akhtar M. Bundle branch reentrant ventricular tachycardia: cumulative experience in 48 patients. J Cardiovasc Electrophysiol 1993;4:253-62.
267. 265. Leclercq JF, Chouty F, Cauchemez B, Leenhardt A, Coumel P, Slama R. Results of electrical fulguration in arrhythmogenic right ventricular disease. Am J Cardiol 1988;62:220-4.
268. 266. Bocker D, Haverkamp W, Block M, Borggrefe M, Hammel D, Breithardt G. Comparison of D,L-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease. Circulation 1996;94:151-7.
269. 267. Wever EF, Hauer RN, van Capelle FL, et al. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 1995;91:2195-2203.
270. 268. Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J 1994;127:1139-44.
271. 269. Krol RB, Saksena S. Clinical trials of antiarrhythmic drugs in recipients of implantable cardioverter-defibrillators. In: Saksena S, Luderitz B, editors. Interventional Electrophysiology. 2nd ed. Armonk (NY): Futura Publishing Co, 1996:365-75.
272. 270. Lehmann MH, Saksena S. Implantable cardioverter defibrillators in cardiovascular practice: report of the Policy Conference of the North American Society of Pacing and Electrophysiology. NASPE Policy Conference Committee. PACE Pacing Clin Electrophysiol 1991;14:969-79.
273. 271. Steinbeck G, Dorwarth U, Mattke S, et al. Hemodynamic deterioration during ICD implant: predictors of high-risk patients. Am Heart J 1994;127: 1064-7.
274. 272. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981;47:525-31.
275. 273. Johnson RA, Palacios I. Dilated cardiomyopathies of the adult (first of two parts). N Engl J Med 1982;307:1051-8.
276. 274. Follansbee WP, Michelson EL, Morganroth J. Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac death. Ann Intern Med 1980;92:741-7.
277. 275. Milner PG, DiMarco JP, Lerman BB. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. PACE Pacing Clin Electrophysiol 1988;11:562-8.
278. 276. Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol 1996;78:703-6.
279. 277. Garson AJ, Dick MI, Fournier A, et al. The long QT syndrome in children: an international study of 287 patients. Circulation 1993;87:1866-72.
280. 278. Schwartz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J 1985;109:399-411.
281. 279. Topaz O, Perin E, Cox M, Mallon SM, Castellanos A, Myerburg RJ. Young adult survivors of sudden cardiac arrest: analysis of invasive evaluation of 22 subjects. Am Heart J 1989;118:281-7.
282. 280. Viskin S, Belhassen B. Idiopathic ventricular fibrillation. Am Heart J 1990;120:661-71.
283. 281. Wellens HJ, Lemery R, Smeets JL, et al. Sudden arrhythmic death without overt heart disease. Circulation 1992;85 Suppl I:I-92-7.
284. 282. McKenna WJ, Franklin RC, Nihoyannopoulos P, Robinson KC, Deanfield JE. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol 1988;11:147-53.
285. 283. Nicod P, Polikar R, Peterson KL. Hypertrophic cardiomyopathy and sudden death. N Engl J Med 1988;318:1255-7.
286. 284. Fananapazir L, Epstein SE. Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest. Am J Cardiol 1991;67:280-7.
287. 285. Hamilton RM, Dorian P, Gow RM, Williams WG. Five-year experience with implantable defibrillators in children. Am J Cardiol 1996;77:524-6.
288. 286. Marcus FI, Fontaine GH, Guiraudon G, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation 1982;65:384-98.
289. 287. Breithardt G, Wichter T, Haverkamp W, et al. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J 1994;127:1151-8.
290. 288. Wichter T, Block M, Bocker D, Borggrefe G, Breithardt G. Cardioverter-defibrillator therapy in a high-risk subgroup of patients with arrhythmogenic right ventricular disease [abstract]. J Am Coll Cardiol 1993;21:127A.
291. 289. Krol RB, Morady F, Flaker GC, et al. Electrophysiologic testing in patients with unexplained syncope: clinical and noninvasive predictors of outcome. J Am Coll Cardiol 1987;10:358-63.
292. 290. DiMarco JP, Garan H, Harthorne JW, Ruskin JN. Intracardiac electrophysiologic techniques in recurrent syncope of unknown case. Ann Intern Med 1981;95:542-8.
293. 291. Akhtar M, Shenasa M, Denker S, Gilbert CJ, Rizwi N. Role of cardiac electrophysiologic studies in patients with unexplained recurrent syncope. PACE Pacing Clin Electrophysiol 1983;6:192-201.
294. 292. Akhtar M, Garan H, Lehmann MH, Troup PJ. Sudden cardiac death: management of high-risk patients. Ann Intern Med 1991;114:499-512.
295. 293. Kron J, Silka MJ, Ohm OJ, et al. Preliminary experience with nonthoracotomy implantable cardioverter defibrillators in young patients. PACE Pacing Clin Electrophysiol 1994;17:26-31.
296. 294. Driscoll DJ, Edwards WD. Sudden unexpected death in children and adolescents. J Am Coll Cardiol 1985;5 Suppl 6:118B-21B.
297. 295. Walsh CK, Krongrad E. Terminal cardiac electrical activity in pediatric patients. Am J Cardiol 1983;51:557-61.
298. 296. Eisenberg M, Bergner L, Hallstrom A. Epidemiology of cardiac arrest and resuscitation in children. Ann Emerg Med 1983;12:672-4.
299. 297. Silka MJ, Kron J, Cutler JE, McAnulty JH. Analysis of programmed stimulation methods in the evaluation of ventricular arrhythmias in patients 20 years old and younger. Am J Cardiol 1990;66:826-30.
300. 298. Garson AJ. Ventricular arrhythmias after repair of congenital heart disease: who needs treatment? Cardiol Young 1991;1:177-81.
301. 299. Keane JF, Driscoll DJ, Gersony WM, et al. Second natural history study of congenital heart defects: results of treatment of patients with aortic valvular stenosis. Circulation 1993;87 Suppl I:I-16-27.
302. 300. Evans RW, Manninen DL, Dong FB, Frist WH, Kirklin JK. The medical and surgical determinants of heart transplantation outcomes: the results of a consensus survey in the United States. J Heart Lung Transplant 1993;12: 42-5.
303. 301. Maron BJ, Fananapazir L. Sudden cardiac death in hypertrophic cardiomyopathy. Circulation 1992;85 Suppl I:I-57-63.
304. 302. Kaminer SJ, Pickoff AS, Dunnigan A, Sterba R, Wolff GS. Cardiomyopathy and the use of implanted cardio-defibrillators in children. PACE Pacing Clin Electrophysiol 1990;13:593-7.
305. 303. Bigger JT, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984;69:250-8.
306. 304. Buxton AE, Marchlinski FE, Waxman HL, Flores BT, Cassidy DM, Josephson ME. Prognostic factors in nonsustained ventricular tachycardia. Am J Cardiol 1984;53:1275-9.
307. 305. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-8.
308. 306. Sim I, McDonald KM, Lavori PW, Norbutas CM, Hlatky MA Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death. Circulation 1997;96:2823-9.
309. 307. Wilber DJ, Olshansky B, Moran JF, Scanlon PJ. Electrophysiological testing and nonsustained ventricular tachycardia: use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation 1990;82:350-8.
310. 308. Saksena S, Moss AJ, Giorgeberidze I, et al. Factors associated with shock delivery in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) [abstract]. J Am Coll Cardiol 1997;29 Suppl A:79A.
311. 309. Bigger JT Jr for the CABG-Patch Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 1997;337:1569-75.
312. 310. Grimm M, Wieselthaler G, Avanessian R, et al. The impact of implantable cardioverter-defibrillators on mortality among patients on the waiting list for heart transplantation. J Thorac Cardiovasc Surg 1995;110:532-9.
313. 311. Sweeney MO, Ruskin JN, Garan H, et al. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation 1995;92:3273-81.
314. 312. Bigger JT Jr. Why patients with congestive heart failure die: arrhythmias and sudden cardiac death. Circulation 1987;75(5 Pt 2):IV-28-35.
315. 313. Defibrilat Study Group. Actuarial risk of sudden death while awaiting cardiac transplantation in patients with atherosclerotic heart disease. Am J Cardiol 1991;68:545-6.
316. 314. Bigger JT Jr. Prophylactic use of implantable cardioverter defibrillators: medical, technical, economic considerations. PACE Pacing Clin Electrophysiol 1991;14:376-80.
317. 315. Stevenson WG, Stevenson LW, Middlekauff HR, Saxon LA. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation 1993;88:2953-61.
318. 316. Vlay SC, Olson LC, Fricchione GL, Friedman R. Anxiety and anger in patients with ventricular tachyarrhythmias: responses after automatic internal cardioverter defibrillator implantation. PACE Pacing Clin Electrophysiol 1989;12:366-73.
319. 317. Luderitz B, Jung W, Deister A, Marneros A, Manz M. Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias. PACE Pacing Clin Electrophysiol 1993;16:1815-21.
320. 318. O'Donoghue S, Platia EV, Brooks-Robinson S, Mispireta L. Automatic implantable cardioverter-defibrillator: is early implantation cost-effective? J Am Coll Cardiol 1990;16:1258-63.
321. 319. Kuppermann M, Luce BR, McGovern B, Podrid PJ, Bigger JT, Ruskin JN. An analysis of the cost effectiveness of the implantable defibrillator. Circulation 1990;81:91-100.
322. 320. Saksena S, Madan N, Lewis C. Implanted cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias. Prog Cardiovasc Dis 1996;38:445-54.
323. 321. Kupersmith J, Hogan A, Guerrero P, et al. Evaluating and improving the cost-effectiveness of the implantable cardioverter-defibrillator. Am Heart J 1995;130:507-15.
324. 322. Larson GC, Manolis AS, Sonnenberg FA, et al. Cost-effectiveness of the implantable cardioverter-defibrillator: effect of improved battery life and comparison with amiodarone therapy. J Am Coll Cardiol 1992;19:1323-34.
325. 323. Owens DK, Sanders GD, Harris RA, et al. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med 1997;126:1-12.
326. 324. Mushlin AL. Cost-effectiveness of ICDs versus conventional therapy in the Multicenter Automatic Defibrillator Implantation Trial (MADIT). Presented at the North American Society of Pacing and Electrophysiology 18th Annual Scientific Sessions; May 1997; New Orleans, La.
327. 325. Wood MA. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defribillator. J Am Coll Cardiol 1994;24:1692-9.
328. 326. Pinski SL, Fahy GJ. The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation 1995;92:1651-64.
329. 327. Raitt MH, Dolack GL, Kudenchuk PJ, et al. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation. Circulation 1995;91:1996-2001.
330. 328. Scheinman MM, Akhtar M, Brugada P, et al. Teaching objectives for fellowship programs in clinical electrophysiology. J Am Coll Cardiol 1988;12:255-61.
331. 329. Faust M, Fraser J, Schurig L, et al. Educational guidelines for the clinically associated professional in cardiac pacing and electrophysiology. PACE Pacing Clin Electrophysiol 1990;13:1448-55.
332. 330. Fetter JG, Stanton MS, Benditt DG, Trusty J, Collins J. Transtelephonic monitoring and transmission of stored arrhythmia detection and therapy data from an implantable cardioverter defibrillator. PACE Pacing Clin Electrophysiol 1995;18:1531-9.
333. 331. Epstein AE, Miles WM, Benditt DG, et al. Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology. Circulation 1996;94:1147-66.
334. 332. Jung W, Luderitz B. European policy on driving for patients with implantable cardioverter-defibrillators. PACE Pacing Clin Electrophysiol 1995;19: 981-4.
335. 333. Maron BJ, Poliac LC, Kaplan JA, Mueller FO. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med 1995;333:337-42.